IFNA13 Antikörper (C-Term)
Kurzübersicht für IFNA13 Antikörper (C-Term) (ABIN926586)
Target
Alle IFNA13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Aufreinigung
- Purified
-
Immunogen
- IFNA13 antibody was raised in rabbit using the C terminal of IFNA13 as the immunogen
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator.
-
Kommentare
-
IFNA13 Blocking Peptide, (ABIN939424), is also available for use as a blocking control in assays to test for specificity of this IFNA13 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- IFNA13 (Interferon, alpha 13 (IFNA13))
-
Andere Bezeichnung
- IFNA13
-
Hintergrund
- IFNA13 is produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. Synonyms: Polyclonal IFNA13 antibody, Anti-IFNA13 antibody, interferon, alpha 13 antibody, IFNA1 antibody.
-
Pathways
- JAK-STAT Signalweg, Hepatitis C
Target
-